Media Advisory BIO2005 Journalists Invited to Welcoming Brunch “Treating Cancer: New Approaches from Emerging Companies”
BIO 2005 opens for the press with the annual media brunch Sunday, June 19 at 11:00 a.m. in the Pennsylvania Convention Center. The brunch's theme is “Treating Cancer: New Approaches from Emerging Companies” and will feature experts from small and emerging biotech companies and actor and cancer survivor Richard Roundtree. Space is limited. A RSVP is required for attendance. RSVP by e-mail to firstname.lastname@example.org.
Richard Roundtree, actor and cancer survivor
Carl H. June, M.D., Director of Translational Research Programs and professor of pathology and laboratory medicine, Abramson Family Cancer Research Institute, Abramson Cancer Center, University of Pennsylvania
Donald L. Drakeman, J.D., Ph.D., President and Chief Executive Officer of Medarex, Inc.
Steven Friedman, M.D., Senior Vice President, Biology Discovery, Incyte Corporation
John M. Gill, Chief Executive Officer, Gentara Corporation
Stephen A. Sherwin, M.D., Chairman and Chief Executive Officer, Cell Genesys, Inc.
When: Sunday, June 19, 2005
Time: 11 a.m. – 12:30 p.m.
Where: Philadelphia Convention Center, Room 204A/B
Additional speaker information available at http://www.bio.org/events/2005/media/brunch.asp
BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and 31 other nations. BIO members are involved in the research and development of healthcare, agricultural, industrial and environmental biotechnology products.